478 related articles for article (PubMed ID: 26270651)
1. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
2. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
[TBL] [Abstract][Full Text] [Related]
4. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
[TBL] [Abstract][Full Text] [Related]
6. Incidence and evolution of venous thrombosis during the first 3 months after irreversible electroporation of malignant hepatic tumours.
Bäumler W; Sebald M; Einspieler I; Wiggermann P; Schicho A; Schaible J; Lürken L; Dollinger M; Stroszczynski C; Beyer LP
Sci Rep; 2019 Dec; 9(1):19876. PubMed ID: 31882716
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
8. Vessel patency post irreversible electroporation.
Narayanan G; Bhatia S; Echenique A; Suthar R; Barbery K; Yrizarry J
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1523-9. PubMed ID: 25212418
[TBL] [Abstract][Full Text] [Related]
9. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Occlusion of Hepatic Blood Vessels after Irreversible Electroporation of Liver Tumors.
Tamura M; Pedersoli F; Schulze-Hagen M; Zimmerman M; Isfort P; Kuhl CK; Schmitz-Rode T; Bruners P
J Vasc Interv Radiol; 2020 Dec; 31(12):2033-2042.e1. PubMed ID: 33267950
[TBL] [Abstract][Full Text] [Related]
11. Effects of Microwave Ablation on Arterial and Venous Vasculature after Treatment of Hepatocellular Carcinoma.
Chiang J; Cristescu M; Lee MH; Moreland A; Hinshaw JL; Lee FT; Brace CL
Radiology; 2016 Nov; 281(2):617-624. PubMed ID: 27257951
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical sequelae of portal and hepatic venous thrombosis following percutaneous cryoablation of liver tumors.
Sainani NI; Silverman SG; Tuna IS; Aghayev A; Shyn PB; Tuncali K; Kadiyala V; Tatli S
Abdom Radiol (NY); 2016 May; 41(5):970-7. PubMed ID: 27193794
[TBL] [Abstract][Full Text] [Related]
13. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
[TBL] [Abstract][Full Text] [Related]
15. Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
Bäumler W; Schicho A; Schaible J; Verloh N; Senk K; Wiggermann P; Stroszczynski C; Beyer LP
PLoS One; 2020; 15(11):e0242093. PubMed ID: 33201902
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.
Barabasch A; Distelmaier M; Heil P; Krämer NA; Kuhl CK; Bruners P
Invest Radiol; 2017 Jan; 52(1):23-29. PubMed ID: 27379698
[TBL] [Abstract][Full Text] [Related]
18. Postoperative inflammation as a possible cause of portal vein thrombosis after irreversible electroporation for locally advanced pancreatic cancer.
Su JJ; Su M; Xu K; Wang PF; Yan L; Lu SC; Gu WQ; Chen YL
World J Gastroenterol; 2017 Aug; 23(32):6003-6006. PubMed ID: 28932093
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis after radiofrequency ablation for hepatocellular carcinoma.
Kim AY; Rhim H; Park M; Lee MW; Kim YS; Choi D; Lim HK
AJR Am J Roentgenol; 2011 Dec; 197(6):1474-80. PubMed ID: 22109305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
